These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25750553)

  • 1. Microvascular angina: angina that predominantly affects women.
    Park JJ; Park SJ; Choi DJ
    Korean J Intern Med; 2015 Mar; 30(2):140-7. PubMed ID: 25750553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of microvascular angina pectoris.
    Lanza GA; Parrinello R; Figliozzi S
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):31-40. PubMed ID: 24174173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary microvascular dysfunction. An update].
    Lamendola P; Di Franco A; Tarzia P; Milo M; Laurito M; Lanza GA
    Recenti Prog Med; 2011 Sep; 102(9):329-37. PubMed ID: 21947187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of Ischemic Heart Disease.
    Kaski JC; Crea F; Gersh BJ; Camici PG
    Circulation; 2018 Oct; 138(14):1463-1480. PubMed ID: 30354347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular angina (Cardiac Syndrome X) from a historical overview, epidemiology, pathophysiology to treatment recommendations - a minireview.
    Jarczewski J; Jarczewska A; Boryczko A; Poniatowski A; Furgała A; Surdacki A; Gil K
    Folia Med Cracov; 2021 Sep; 61(3):95-114. PubMed ID: 34882667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.
    Mygind ND; Michelsen MM; Pena A; Frestad D; Dose N; Aziz A; Faber R; Høst N; Gustafsson I; Hansen PR; Hansen HS; Bairey Merz CN; Kastrup J; Prescott E
    J Am Heart Assoc; 2016 Mar; 5(3):e003064. PubMed ID: 27068634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular angina: prevalence, pathophysiology and therapy.
    Villano A; Lanza GA; Crea F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e36-e39. PubMed ID: 29538142
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolving strategies for the treatment of microvascular angina in women.
    Duvernoy CS
    Expert Rev Cardiovasc Ther; 2012 Nov; 10(11):1413-9. PubMed ID: 23244362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary endothelial dysfunction in non-obstructive coronary artery disease: Risk, pathogenesis, diagnosis and therapy.
    Shaw J; Anderson T
    Vasc Med; 2016 Apr; 21(2):146-55. PubMed ID: 26675331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.
    Ford TJ; Yii E; Sidik N; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M; Robertson K; Hood S; McGeoch R; McDade R; McCartney P; Corcoran D; Collison D; Rush C; Stanley B; McConnachie A; Sattar N; Touyz RM; Oldroyd KG; Berry C
    Circ Cardiovasc Interv; 2019 Dec; 12(12):e008126. PubMed ID: 31833416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block - a case report.
    Yuriivna Osovska N; Vitaliivna Kuzminova N
    Pol Merkur Lekarski; 2016 Dec; 41(246):287-292. PubMed ID: 28024133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina.
    Russo G; Di Franco A; Lamendola P; Tarzia P; Nerla R; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
    Cardiovasc Drugs Ther; 2013 Jun; 27(3):229-34. PubMed ID: 23338814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal Diagnostics and Therapy for Microvascular Angina Pectoris].
    Ong P; Sechtem U
    Dtsch Med Wochenschr; 2017 Oct; 142(21):1586-1593. PubMed ID: 29046002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of microvascular angina among patients with stable symptoms in the absence of obstructive coronary artery disease: a systematic review.
    Aribas E; Roeters van Lennep JE; Elias-Smale SE; Piek JJ; Roos M; Ahmadizar F; Arshi B; Duncker DJ; Appelman Y; Kavousi M
    Cardiovasc Res; 2022 Feb; 118(3):763-771. PubMed ID: 33677526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different definition of microvascular angina.
    Suzuki H
    Eur J Clin Invest; 2015 Dec; 45(12):1360-6. PubMed ID: 26480027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Microvascular Dysfunction, Microvascular Angina, and Management.
    Löffler AI; Bourque JM
    Curr Cardiol Rep; 2016 Jan; 18(1):1. PubMed ID: 26694723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests.
    Radico F; Cicchitti V; Zimarino M; De Caterina R
    JACC Cardiovasc Interv; 2014 May; 7(5):453-63. PubMed ID: 24746648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for coronary microvascular dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):65-71. PubMed ID: 27533969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranolazine: Drug overview and possible role in primary microvascular angina management.
    Cattaneo M; Porretta AP; Gallino A
    Int J Cardiol; 2015 Feb; 181():376-81. PubMed ID: 25555283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between coronary microvascular function and angina status in patients with stable microvascular angina.
    Di Franco A; Villano A; Di Monaco A; Lamendola P; Russo G; Stazi A; Scavone G; Nerla R; Sestito A; Lanza GA; Crea F
    Eur Rev Med Pharmacol Sci; 2014; 18(3):374-9. PubMed ID: 24563437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.